Common medications used to treat gout, such as allopurinol, are associated with a reduced risk of heart attack and stroke. A large study involving over 100,000 patients found that effectively lowering uric acid levels below the medically recognized threshold of 6 mg/dL correlated with a 9 percent lower risk of major cardiovascular events over a five-year period.
Individuals with gout are known to have a higher risk of heart disease and stroke, potentially due to the inflammatory nature of the condition. This research indicates that by managing uric acid levels, which form crystals causing gout flares, the treatment may also mitigate these cardiovascular risks.
The study observed that the lower the uric acid levels achieved, the greater the health benefit, impacting both gout flares and cardiovascular incidents. Notably, patients already at higher cardiovascular risk appeared to experience a more pronounced protective effect from the gout treatment. While the exact mechanism requires further investigation, the findings suggest a strong association between inflammation management in gout and improved heart health outcomes. The research was published in JAMA Internal Medicine.